Mesa Laboratories, Inc.
MLAB
$61.66
-$1.43-2.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 99.75% | 99.22% | -26,412.55% | -34,160.95% | -13,860.80% |
| Total Depreciation and Amortization | -13.44% | -22.32% | -30.67% | -18.98% | -12.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.38% | -93.23% | 2,644.54% | 2,030.19% | 1,819.11% |
| Change in Net Operating Assets | -110.49% | 15.59% | 1,103.30% | 146.19% | 187.30% |
| Cash from Operations | -14.84% | 6.76% | 8.15% | 1.20% | 10.32% |
| Capital Expenditure | -36.98% | -65.52% | -31.69% | -21.15% | 30.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 101.21% | -1,490.69% | -1,490.69% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.36% | 94.47% | 96.30% | -873.53% | -758.86% |
| Total Debt Issued | -92.73% | 3.47% | 3.47% | -- | -- |
| Total Debt Repaid | 60.04% | -246.63% | -291.73% | -303.46% | -153.57% |
| Issuance of Common Stock | 638.55% | 638.55% | -85.53% | -87.13% | -93.56% |
| Repurchase of Common Stock | -21.84% | -21.84% | -7,180.00% | -111.01% | 20.61% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.78% | -0.61% | -0.67% | -0.67% | -0.85% |
| Other Financing Activities | -730.17% | 46.64% | -132.87% | -408.10% | -83.33% |
| Cash from Financing | -233.07% | -236.49% | -200.44% | 205.40% | 179.48% |
| Foreign Exchange rate Adjustments | 1,888.67% | 464.07% | 107.92% | 742.61% | 113.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.25% | 80.98% | 28.69% | -448.15% | 65.67% |